LipoSeuticals' Series A Round

LipoSeuticals raised a round of funding on June 29, 2017. Investors include Delos Capital.

LipoSeuticals has developed a sugar-lipid polymer-based formulation, Sulocence, which boosts drug stability and solubility.…

Articles about LipoSeuticals' Series A Round: